Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
Democrats are ready to fight over the GOP’s tax plans, and Bessent will be the face of the administration’s economic agenda.

How Democrats will handle Bessent, Turner noms

When the Senate Finance Committee brings Scott Bessent in Thursday morning, Democratic tax writers will have their first big chance to put down a marker on President-elect Donald Trump’s economic nominees.

Democrats on the panel are mostly expected to oppose Bessent’s nomination for Treasury secretary, according to multiple people familiar with members’ thinking. But it’s not out of the question that the hedge fund billionaire could draw some bipartisan support.

Subscripion logo

You're seeing a preview of our Premium Policy: The Vault financial services and tax policy coverage. Read the full story by subscribing here.

Presented by Pharmaceutical Reform Alliance

Americans know who to blame for rising drug prices: Big Pharma. A majority of Republicans, Democrats, & Independents all believe Big Pharma’s focus on profits keeps drug prices high. Let’s hold Big Pharma accountable – it’s an issue we’re united on.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.